News

New QC-Scheme for GanglioCombi – Summary from PNS 2025 Poster Presentation We are pleased to inform you about recent developments presented at the Peripheral Nerve Society (PNS) Annual Meeting 2025 in Edinburgh, where we showcased our latest work on improving the quality control of the multiparametric GanglioCombi IVD test kits (BÜHLMANN GanglioCombi® MAG ELISA, in

BÜHLMANN Laboratories AG today announced the appointment of Eric Hrimech to the newly created position of global Chief Commercial Officer (CCO).

BÜHLMANN Laboratories AG announced the appointment of Christian Eberle as its new CEO.

Thanks for connecting with us at ECCO 2025 in Berlin! We enjoyed discussing how IBDoc® and Quantum Blue® are advancing IBD care.